MedTrace Logo

DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

NCT05604573 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-11-03

No results posted yet for this study

Summary

Based on the cell free nucleic acid analysis information of blood samples and genetic mutation profile of EUS-FNB tissue from pancreatic cancer, the concordance between them is evaluated. And based on this information, biomarkers for diagnosis, treatment, and prognosis of pancreatic cancer are explored.

Conditions

Interventions

DIAGNOSTIC_TEST

cell free DNA in blood, genetic mutation in tissue

Diagnostic test for cell free DNA in blood, genetic mutation in tissue

Sponsors & Collaborators

  • GENECAST Co., Ltd.

    collaborator UNKNOWN

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-09
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05604573 on ClinicalTrials.gov